Home›Companies›Food & Agriculture›EmGenisys

EMGenisys, Inc.

Embryo assessment software for livestock producers and reproductive specialists.

Updated Nov 10, 2026·Latest SEC filing Mar 24, 2026·Suggest an edit

About EmGenisys

EmGenisys is a private company based in Houston, Texas, incorporated in 2024 in Delaware. It has reported $521,435 raised in one offering on Form D since October 2024. Its chief executive is Cara Wells.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 25, 2024Oct 2, 2024amended Mar 24, 2026$521,435of $1.5M target4$130KEquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on EmGenisys's Form D filed Mar 24, 2026.

TS
Thomas Smith
Director
CW
Cara Wells
CEO & Founder, director
MJ
Mike Jung
Director
MR
Michael Rea
Director

Sources

  1. SECEMGenisys, Inc. Form D, filed Oct 2, 2024
  2. SECEMGenisys, Inc. filing history
  3. CompanyEmGenisys team
  4. InvestorTall Grass Ventures: EmGenisys financing announcement